# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-118069
Filing Date
2024-04-26
Accepted
2024-04-26 16:13:56
Documents
9
Period of Report
2024-05-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d674951ddef14a.htm | DEF 14A | 537040
2 | GRAPHIC | g674951g01a01.jpg | GRAPHIC | 37467
3 | GRAPHIC | g674951g01t01.jpg | GRAPHIC | 439360
4 | GRAPHIC | g674951g01t02.jpg | GRAPHIC | 257633
5 | GRAPHIC | g674951g06a06.jpg | GRAPHIC | 55920
6 | GRAPHIC | g674951g13j07.jpg | GRAPHIC | 17377
7 | GRAPHIC | g674951g51w01.jpg | GRAPHIC | 53138
8 | GRAPHIC | g674951g73l41.jpg | GRAPHIC | 60831
9 | GRAPHIC | g674951g90t91.jpg | GRAPHIC | 23079
| Complete submission text file | 0001193125-24-118069.txt |  | 1840577

Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39659 | Film No.: 24883913
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)